Promoting HPV Vaccination Among Young Adults in Texas (NCT05057312) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Promoting HPV Vaccination Among Young Adults in Texas
United States1,200 participantsStarted 2021-07-26
Plain-language summary
This clinical trial studies how to improve the human papillomavirus (HPV) vaccination rate in young adults in Texas. This trial aims to learn more about how researchers and health care providers can increase HPV vaccination among college students.
Who can participate
Age range18 Years – 26 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18-26 years. This criterion is based on the CDC recommendation of vaccination up to 26 years of age and the fact that individuals 18 years and older can consent by themselves for on-site vaccination
* Ability to read and understand English
* Self-identification as not yet having received any HPV vaccine injections. Self-identification is justified because it is safe to be vaccinated again, which could happen if a previously vaccinated person forgets their vaccination. Furthermore, in a person previously vaccinated with an older version of the vaccine, which targeted fewer HPV types, receiving the newer version would be advantageous and not cause any harm. Alternatives to self-identification, such as obtaining medical records from doctors' offices, would be very challenging for young adults, especially for those who do not remember when and where they might have received vaccination
* Access to a smart phone, tablet or computer that is connected to the internet
* Current enrollment in one of the participating schools with an anticipated continuous enrollment of at least 9 months
Exclusion Criteria:
* Being pregnant
* Having a life-threatening allergy to any component of the HPV vaccine
What they're measuring
1
Rate of human papillomavirus (HPV) vaccination initiation